Renalytix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Renalytix generated cash of -$30,111,000, which is more than the previous year. Cash used in financing activities reached the amount of $10,250,000 last year. Net change in cash is therefore -$20,002,000.
Cash Flow
| 2013 | 8.66B | -1.59B | -7.42B |
|---|---|---|---|
| 2014 | 5.54B | -341M | -5.19B |
| 2016 | 7.04B | -3.18B | -3.07B |
| 2018 | 7.87B | -5.87B | -2.02B |
| 2019 | -3.99M | -13.04M | 26.24M |
| 2020 | -10.06M | -485K | 16.54M |
| 2021 | -24.63M | -741K | 77.23M |
| 2022 | -45.74M | -694K | 25.51M |
| 2023 | -32.67M | 0 | 15.11M |
| 2024 | -30.11M | -4K | 10.25M |
RENX.L Cash Flow Statement (2013 – 2024)
| 2024 | 2023 | 2022 | 2020 | 2019 | 2019 | 2017 | 2016 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 24.68M | 41.33M | 65.15M | 13.29M | 7.29M | 82K | 3.19B | 2.12B | 2.04B | 2.92B |
Operating activities | ||||||||||
Net income | -33.45M | -46.22M | -49.62M | -35.78M | -10.61M | -6.51M | 6.02B | 5.18B | 5.17B | 6.66B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 364K | 2.49M | 2.61M | 2.09M | -485K | 1.12M | 2.02B | 1.46B | 1.12B | 1.58B |
Stock-based compensation expense | 1.71M | 2.93M | 4.62M | 2.18M | 1.15M | 532K | 284M | 198M | 188M | 333.26M |
| Deferred income tax benefit | 1.71M | 2.93M | 4.62M | 2.18M | 1.15M | 532K | 284M | 198M | 188M | 333.26M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 54K | 125K | -307K | 1.37B | -499.15M | 0 | -506M | 142M | 82M | -1.26B |
Inventories | 0 | 442K | -807K | -27K | -326K | 0 | -104M | 190M | -47M | 231.35M |
Accounts payable | 106K | 80K | 1.41M | 0 | 0 | 302.95K | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -30.11M | -32.67M | -45.74M | -24.63M | -10.06M | -3.99M | 7.87B | 7.04B | 5.54B | 8.66B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -1.33M | -973K | -4.96M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4K | 0 | -694K | -1.63M | -1.31M | -13.04M | -1.50B | -1.80B | -1.89B | -2.46B |
Acquisitions Net | 0 | 0 | 0 | 472K | -122K | 11.98M | -4.89B | -1.73B | -313M | 0 |
Cash generated by investing activities | -4K | 0 | -694K | -741K | -485K | -13.04M | -5.87B | -3.18B | -341M | -1.59B |
Financing activities | ||||||||||
Common Stock Issued | 13.62M | 20.55M | 9.21M | 77.23M | 16.37M | 29.11M | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -3.91B | -3.60B | -3.18B | -4.12B |
Repurchases of common stock | 0 | 0 | 0 | 5.22B | -225.46M | 0 | -5.21B | -257M | -467M | 0 |
Repayments of term debt | -1.66M | -3.18M | 18.02M | -202K | -4.94B | -1.06M | -5.75B | -1.51B | -147M | 0 |
Cash used in financing activities | 10.25M | 15.11M | 25.51M | 77.23M | 16.54M | 26.24M | -2.02B | -3.07B | -5.19B | -7.42B |
Net Change In Cash | -20.00M | -16.65M | -23.82M | 51.86M | 5.99M | 9.20M | -29M | 1.07B | -134M | -108.22M |
Cash at end of period | 4.68M | 24.68M | 41.33M | 65.15M | 13.29M | 9.28M | 3.16B | 3.19B | 1.91B | 2.81B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |